Thomas Jouary

16.4k total citations
83 papers, 2.1k citations indexed

About

Thomas Jouary is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Thomas Jouary has authored 83 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 38 papers in Molecular Biology and 20 papers in Dermatology. Recurrent topics in Thomas Jouary's work include Melanoma and MAPK Pathways (23 papers), Cutaneous Melanoma Detection and Management (22 papers) and melanin and skin pigmentation (14 papers). Thomas Jouary is often cited by papers focused on Melanoma and MAPK Pathways (23 papers), Cutaneous Melanoma Detection and Management (22 papers) and melanin and skin pigmentation (14 papers). Thomas Jouary collaborates with scholars based in France, Germany and Italy. Thomas Jouary's co-authors include Alain Taı̈eb, Khaled Ezzedine, B. Vergier, Jean‐Philippe Merlio, M. Beylot‐Barry, Elodie Laharanne, Jean‐Jacques Grob, Julien Sénéschal, Muriel Cario and C. Léauté‐Labrèze and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Thomas Jouary

80 papers receiving 2.0k citations

Peers

Thomas Jouary
Naohito Hatta Japan
Thomas G. Salopek Canada
T Castel Spain
Makiko Kawaguchi Japan
Young Kyung Bae South Korea
Simona Osella‐Abate Italy
Puay‐Hoon Tan Singapore
Mark Harland United Kingdom
R. Vilella Spain
Gabrina Tragni Italy
Naohito Hatta Japan
Thomas Jouary
Citations per year, relative to Thomas Jouary Thomas Jouary (= 1×) peers Naohito Hatta

Countries citing papers authored by Thomas Jouary

Since Specialization
Citations

This map shows the geographic impact of Thomas Jouary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Jouary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Jouary more than expected).

Fields of papers citing papers by Thomas Jouary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Jouary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Jouary. The network helps show where Thomas Jouary may publish in the future.

Co-authorship network of co-authors of Thomas Jouary

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Jouary. A scholar is included among the top collaborators of Thomas Jouary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Jouary. Thomas Jouary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Louveau, Baptiste, Fanélie Jouenne, Barouyr Baroudjian, et al.. (2024). Skin adnexal carcinomas DNA genomic profiling uncovers oncogenic pathways and potential therapeutic targets. SHILAP Revista de lepidopterología. 2. 100206–100206. 1 indexed citations
2.
3.
Stockfleth, Eggert, Thomas Jouary, Francesca Farnetani, et al.. (2023). Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial. Dermatology and Therapy. 13(4). 1013–1027. 5 indexed citations
4.
Guillot, B., A. Dupuy, Marc Pracht, et al.. (2019). Actualisation des données concernant le mélanome stade III : nouvelles recommandations du groupe français de cancérologie cutanée. Annales de Dermatologie et de Vénéréologie. 146(3). 204–214. 8 indexed citations
5.
Bouché, Olivier, Méher Ben Abdelghani, Jean-Luc Labourey, et al.. (2019). Management of skin toxicities during panitumumab treatment in metastatic colorectal cancer. World Journal of Gastroenterology. 25(29). 4007–4018. 8 indexed citations
6.
Tourneau, C. Le, Brigitte Dréno, Youlia Kirova, et al.. (2016). First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma. British Journal of Cancer. 114(11). 1199–1205. 30 indexed citations
7.
Guillot, B., S. Dalac, A. Dupuy, et al.. (2016). Actualisation des recommandations de prise en charge du mélanome stade I à III. Bulletin du Cancer. 103(9). 743–752. 3 indexed citations
8.
Basset‐Séguin, Nicole, Axel Hauschild, Jean‐Jacques Grob, et al.. (2015). Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial. The Lancet Oncology. 16(6). 729–736. 170 indexed citations
9.
Rhun, Émilie Le, Christine Mateus, Laurent Mortier, et al.. (2015). Traitement systémique des métastases cérébrales de mélanome. Cancer/Radiothérapie. 19(1). 48–54. 2 indexed citations
10.
Siberchicot, F., et al.. (2015). Sentinel lymph node biopsy for head and neck Merkel cell carcinoma: A preliminary study. European Annals of Otorhinolaryngology Head and Neck Diseases. 132(2). 77–80. 12 indexed citations
11.
Jouary, Thomas, et al.. (2014). Trichofolliculome du cuir chevelu. Annales de Dermatologie et de Vénéréologie. 141(11). 736–737. 1 indexed citations
12.
Haddad, Véronique, B. Vergier, David Cappellen, et al.. (2013). Tumor Homogeneity between Primary and Metastatic Sites for BRAF Status in Metastatic Melanoma Determined by Immunohistochemical and Molecular Testing. PLoS ONE. 8(8). e70826–e70826. 84 indexed citations
13.
Diallo, Abou, Julien Sénéschal, C. Léauté‐Labrèze, et al.. (2012). Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms. British Journal of Dermatology. 168(4). 756–761. 60 indexed citations
14.
Ezzedine, Khaled, Abou Diallo, C. Léauté‐Labrèze, et al.. (2011). Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients. British Journal of Dermatology. 165(1). 44–49. 41 indexed citations
15.
Guedj, Mickaël, V. Descamps, Thomas Jouary, et al.. (2011). Assessment of tyrosinase variants and skin cancer risk in a large cohort of French subjects. Journal of Dermatological Science. 64(2). 127–133. 21 indexed citations
16.
Rezvani, Hamid, Rodrigue Rossignol, Nsrein Ali, et al.. (2010). XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1807(6). 609–619. 45 indexed citations
17.
Vergier, B., Martina Prochazkova‐Carlotti, Arnaud de la Fouchardière, et al.. (2010). Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases. Modern Pathology. 24(5). 613–623. 97 indexed citations
18.
Jouary, Thomas, Céline Legros, Khaled Ezzedine, et al.. (2010). Neoadjuvant chemotherapy: a new criterion for selection of candidate patients for surgery of low tumour burden metastases from malignant melanoma?. British Journal of Dermatology. 163(1). 183–187. 3 indexed citations
19.
Marty, Marion, Elodie Laharanne, Edith Chevret, et al.. (2008). Primary Cutaneous T-Cell Lymphomas Do not Show Specific NAV3 Gene Deletion or Translocation. Journal of Investigative Dermatology. 128(10). 2458–2466. 10 indexed citations
20.
Taı̈eb, Alain, Fanny Morice‐Picard, Thomas Jouary, et al.. (2008). Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non‐segmental vitiligo. Pigment Cell & Melanoma Research. 21(6). 646–652. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naohito Hatta Breakdown of academic impact, for papers by Thomas G. Salopek Breakdown of academic impact, for papers by T Castel Breakdown of academic impact, for papers by Makiko Kawaguchi Breakdown of academic impact, for papers by Young Kyung Bae Breakdown of academic impact, for papers by Simona Osella‐Abate Breakdown of academic impact, for papers by Puay‐Hoon Tan Breakdown of academic impact, for papers by Mark Harland Breakdown of academic impact, for papers by R. Vilella Breakdown of academic impact, for papers by Gabrina Tragni
Rankless by CCL
2026